Finance

Beta
Lists
CLDI:NYSEAMERICAN
Calidi Biotherapeutics Inc
$0.17
-2.87%
(-0.0050) 1D
$0.17
-1.36% (-0.0023)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLDI...
Open
$0.17
High
$0.17
Low
$0.16
Mkt. cap
3.34M
Avg. vol.
7.98M
Volume
1.50M
52-wk high
$19.20
52-wk low
$0.16
EPS
-$5.19
Beta
1.31
Shares outstanding
19.31M
No. of employees
29
Open
$0.17
High
$0.17
Low
$0.16
Mkt. cap
3.34M
Avg. vol.
7.98M
Volume
1.50M
52-wk high
$19.20
52-wk low
$0.16
EPS
-$5.19
Beta
1.31
Shares outstanding
19.31M
No. of employees
29
News stories
From sources across the web
About Calidi Biotherapeutics Inc
CEO-
Employees29
Founded2014
Headquarters-
SectorBiotechnology
Websitecalidibio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.59M
2.36M
2.36M
2.59M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.07M
2.69M
2.11M
1.60M
Operating expense
5.66M
5.05M
4.47M
4.19M
Total operating expenses
5.66M
5.05M
4.47M
4.19M
Operating income
-5.66M
-5.05M
-4.47M
-4.19M
Other non operating income
-41.00K
-82.00K
303.00K
121.00K
EBT including unusual items
-5.76M
-5.17M
-4.06M
-4.10M
EBT excluding unusual items
-5.76M
-5.17M
-4.30M
-4.10M
Income tax expense
4.00K
10.00K
-2.00K
4.00K
Effective tax rate
-0.07%
-0.19%
0.05%
-0.10%
Other operating expenses
-
-
-
-
Net income
-5.72M
-5.15M
-4.06M
-4.11M
Net profit margin
-
-
-
-
Earnings per share
-1.99
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-52.00K
-41.00K
-142.00K
-38.00K
Net interest expenses
-52.00K
-41.00K
-142.00K
-38.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.95M
-4.94M
-3.14M
-3.76M
Gain or loss from assets sale
-
-
-244.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer